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Matrix metalloproteinases (MMPs) are essential to the remodeling of the extracellular matrix. While their upregulation facilitates
aging and cancer, they are essential to epidermal diﬀerentiation and the prevention of wound scars. The pharmaceutical industry
is active in identifying products that inhibit MMPs to prevent or treat aging and cancer and products that stimulate MMPs to
prevent epidermal hyperproliferative diseases and wound scars.
1.Introduction
Matrix metalloproteinases (MMPs) are essential to the
remodeling of the extracellular matrix. While their up-
regulation facilitates aging and cancer, they are essential to
epidermal diﬀerentiation and the prevention of wound scars.
Thepharmaceuticalindustryisactiveinidentifyingproducts
that inhibit MMPs to prevent or treat aging and cancer
and products that stimulate MMPs to prevent epidermal
hyperproliferative diseases and wound scars.
2.MatrixMetalloproteinases
Matrix metalloproteinases (MMPs) are a group of zinc-
dependent extracellular proteinases, also called matrixins
or collagenases, which remodel the extracellular matrix
(ECM) [1–10]. The ECM gives tissue its structural integrity
and predominantly comprises of the ﬁbrillar collagens,
basement membrane, and elastin ﬁbers composed of elastin
and ﬁbrillin [11–13]. There are three predominant groups
of MMPs: collagenases, gelatinases, and stromelysins [1–
13]. The collagenases (MMP-1, -8, -13, and -18) cleave
interstitial (structural) collagens, with MMP-1 as the pre-
dominant one. Gelatinases, primarily MMP-2 and MMP-9,
degrade basement membrane collagens and degrade dena-
tured structural collagens. The stromelysins (MMP-3, -10,
-11, and -19) degrade basement membrane collagens as
well as proteoglycans and matrix glycoproteins. The other
MMP classes include membrane-type MMPs (MT-MMP:
MMP-14, -15, -16, -17, -24, and -25) that activate MMPs,
matrilysins that degrade the basement membrane (MMP-7
and -26), elastase that degrades primarily elastin (MMP-12),
and others (MMP-20, -21, -22, -23, -27, and -28). MMPs
are regulated in expression or activity at several diﬀerent
levels: gene expression, activation, and cellular inhibition
of activity by tissue inhibitors of matrix metalloproteinases
(TIMPs), especially TIMP-1 and TIMP-2 [12]. Epithelial
cells, ﬁbroblasts, neutrophils, and mast cells are some of the
cell types that produce MMPs [1–13].
Transforming growth factor-β (TGF-β) is a predominant
regulator of the expression of MMPs and the ECM [1, 2, 12].
It is secreted extracellularly in a latent form and activated by
proteasestoformthematureTGF-β thatbindstoitsreceptor
complexes to activate Smads and thereby the regulation of
various genes, including MMPs, collagen, and elastin [1, 2,
12]. TGF-β has diﬀerential eﬀects in diﬀerent cell types [1, 2,
12]. It inhibits MMP-1 and stimulates collagen, MMP-2, and
TIMPs in ﬁbroblasts, whereas in keratinocytes it stimulates
the expression of MMPs and inhibits cell growth [1, 2, 12].2 Enzyme Research
3.SkinAging andCarcinogenicEffects
of MatrixMetalloproteinases
3.1. Skin Aging and Its Prevention. Skin aging is the result
the intrinsic chronological aging process superimposed by
environmental factors, predominantly exposure to ultravio-
let (UV) radiation (photoaging) [1, 2, 11–17]. UV radiation
shifts the cellular balance to oxidative stress, inﬂamma-
tion, immunosuppression, and inhibition of TGF-β[1, 2,
12].In addition,UV radiation stimulates proinﬂammatory
and proangiogenic cytokines such as interleukin-1 (IL-1),
interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and
vascular endothelial growth factor (VEGF) [1, 2]. Cellular
damage in photoaged skin includes cell loss, DNA damage,
lipid peroxidation, and compromise of skin barrier function
[13].
Alterations in collagen and elastin of the ECM are
primarily responsible for the clinical manifestations of skin
aging such as wrinkles, sagging, and laxity [1, 2, 11–13,
17, 18]. The atrophy of collagen and elastin ﬁbers in skin
agingispredominantlyfromtheincreasedexpressionoftheir
degradative enzymes, collagenases (MMP-1), gelatinases
(MMP-2 and -9), and elastases [1–13]. Collagen ﬁbers are
degraded by MMP-1 and MMP-2 and the elastin ﬁbers by
elastases, MMP-2, and MMP-9 [12].
Natural products that have been identiﬁed in our lab-
oratory to inhibit MMPs and elastase and simultaneously
stimulate collagen and elastin are Polypodium leucotomos
extract, lutein, and xanthohumol [12–18]. These products
consist of polyphenols, carotenoids, or ﬂavonoids with
antioxidant, anti-inﬂammatory, photoprotective, or anticar-
cinogenic properties [12–18].
P.leucotomosisrichinpolyphenols[1].Itdirectlyinhibits
activities of MMPs [12]. P. leucotomos inhibits expression
of MMPs in epidermal keratinocytes and ﬁbroblasts and
stimulates ﬁbrillar collagens, elastin, and TGF-β in dermal
ﬁbroblasts [12, 13]. In addition, it inhibits cellular oxidative
stress and thereby membrane damage and lipid peroxidation
[13]. Furthermore, it functions as a sunscreen [14, 15].
Lutein is a non-provitamin A carotenoid that inhibits
epidermal hyperproliferation, expansion of mutated ker-
atinocytes, and the inﬁltration of mast cells in response to
solar radiation, and thereby photoaging [16]. The mecha-
nismtolutein’santiagingandantiphotoagingeﬀectsincludes
the inhibition of MMP-to-TIMP ratio in dermal ﬁbroblasts
and the inhibition of cell loss and membrane damage in
ultraviolet radiation-exposed ﬁbroblasts [17].
Xanthohumol, a ﬂavonoid, directly inhibits MMPs (-1,
-3, and -9) and elastase activities while dramatically increas-
ing the expression of types I, III, and V collagens, elastin,
ﬁbrillin-1, and ﬁbrillin-2 in dermal ﬁbroblasts [18].
3.2. Skin Cancer and Its Prevention. Carcinogenesis is char-
acterized by development of tumors from genetic alterations
and immunosuppression. The mechanisms also include
oxidative stress from reactive oxygen species, inﬂammation
and DNA damage [19]. Malignant tumors metastasize, with
MMPs playing a central role [19]. Cancer invasion and
metastasisofvariouscancertypesparallellyincreasedexpres-
sion of MMPs [19]. MMPs activate growth factors such as
TGF-β and VEGF to induce angiogenesis [19]. Furthermore,
MMPs contribute to cancer progression by degrading the
ECM, basement membrane, and E-cadherin molecules that
hold cells together [19–22]. In our laboratory we have
investigated two categories of agents that may prevent or
facilitate carcinogenesis through the regulation of expression
of MMPs: (a) plant extracts or vitamins and (b) hormones.
The plant extracts or vitamins examined in our labora-
tory for MMP regulation in cancer cells are P. leucotomos,
l u t e i na n da s c o r b i ca c i d[ 12, 17, 23, 24]. P. leucotomos
inhibits MMP-1 expression transcriptionally, through AP-
1 promoter sequence, and stimulates the expression of
TIMP-2 in melanoma cells [4]. P. leucotomos in addition
inhibits TGF-β, known to stimulate MMPs in cancer
cells [12]. In photo-carcinogenesis experiments with rats,
lutein inhibits tumor multiplicity, volume, and tumor-free
survival time [16]. Furthermore, lutein inhibits MMP-1
and stimulates TIMPs (-1 and -2), to reduce MMP/TIMP
ratio and thereby carcinogenesis [17]. Ascorbate has dose
dependent diﬀerential eﬀects on cancer cell growth versus
expression of MMPs/metastasis potential [23, 24]. At lower
concentrations, ascorbate inhibits cell growth with dramatic
increases in the expression of MMPs, which are inhibited by
cotreatment with P. leucotomos or gene silencing with MMP
siRNA [23, 24].
4. Beneﬁcial Effects of
MatrixMetalloproteinases
4.1. Epidermal Diﬀerentiationand Wound Repair. Hyperpro-
liferative diseases of the skin are associated with reduced
MMPs[25].TheexpressionofMMP-9isreducedinpsoriatic
keratinocytes, with hyperproliferative keratinocytes [26].
Hyperproliferative skin diseases are also associated with
reduced generation of ceramides (the major lipids of the
stratum corneum) or increased ceramidase activity [27–29].
Ceramides are intracellular messengers of the sphingomyelin
cyclethatactivateproteinkinaseC-alphaandstress-activated
protein kinases to induce apoptosis and epidermal diﬀer-
entiation [30]. The experiments in our laboratory indicate
that ceramide induces MMP-1 expression in keratinocytes
through the activator protein-1 (AP-1) sequence and simul-
taneously inhibits keratinocyte cell viability by apoptosis
[25].ThemechanismofMMP-1generegulationbyceramide
may be through the stimulation of TGF-β, known to inhibit
epidermal cell viability [25].
MMPs are essential to wound healing. They remove
wound debris, facilitate epithelization, and prevent wound
scars from excess collagen [31–34]. In our laboratory, copper
iseﬀectiveininducingwoundhealingwhereastheantibodies
to TGF-β associated with wound scars are ineﬀective [31–
34].
T h eb i o l o g i c a l l ya c t i v ec o n c e n t r a t i o n so fc o p p e rr a n g e
from 1 to 200μM in tissue engineering for wound care,
without toxicity [35]. The lower copper concentrations
(0.3–3μM) stimulate activity of MMPs whereas the higherEnzyme Research 3
concentrations (1–100μM) stimulate the expression of
MMPs in ﬁbroblasts [31] .A d u l tw o u n ds c a r sa r ea t t r i b u t e d
to increased TGF-β expression and subsequent collagen
deposition [33]. However, TGF-β antibodies cause feedback
stimulation of TGF-β [32, 33]. The feedback stimulation
of TGF-β in turn inhibits MMPs and stimulates TIMPs in
ﬁbroblasts, with further scarring potential [32, 33].
5. Summary
MMPs are potent proteases that remodel the ECM. It
is central to the aging and cancer process. Polypodium
leucotomos extract, lutein, and xanthohumol are eﬀective in
inhibiting expression and/or activities of MMPs, and thereby
aging and cancer. Conversely, MMPs can prevent psoriasis
and wound scars. Ceramide stimulates expression of MMP-1
and simultaneously inhibits cell viability. Copper stimulates
MMPs, which may be its mechanism to improve wound
healing. However, the antibodies to TGF-βcause feedback
stimulation of TGF-β, and further scarring potential.
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